Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

Universidad Complutense de Madrid: Madrid, Madrid, ES

2016-10-10 to present | Predoctoral Research Scientist (Organic Chemistry)
Employment
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

Education and qualifications (3)

Universidad Complutense de Madrid : Madrid, Comunidad de Madrid, ES

2016-10-10 to present | PhD Degree in Organic Chemistry. (Organic Chemistry)
Education
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

Institute of Biomedicine of Seville (IBiS) : Seville, ES

2015-09-01 to 2016-05-31 | MSc in Biomedical Research
Education
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

Faculty of Pharmacy: Seville, ES

2010-09-01 to 2015-05-31 | BSc in Pharmacy
Education
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

Funding (4)

New pharmacological strategies based on GPCRs: development of new antagonists of the lysophosphatidic acid receptors LPA1 and LPA2

2016-10 to 2021-03 | Grant
Spanish Ministry of Education (Madrid, SG)
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

Synthesis of novel sulphoraphanes analogues

2016-07 to 2016-09 | Award
Research Foundation of the University of Seville (Seville, Seville, US)
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

Self-assembling cyclodextrin-based nanoparticulate systems for potential use in gene therapy

2015-10 to 2015-11 | Grant
Consejo Superior de Investigaciones Científicas (Seville, ES)
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

In vitro toxicological evaluation of major constituents of oregano and garlic essential oil for potential use in food packaging

2014-01 to 2015-05 | Grant
Ministry of Education, Culture, Sports, Science and Technology (Seville, ES)
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

Works (4)

Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice

Journal of Medicinal Chemistry
2022-08-25 | Journal article
DOI: 10.1021/acs.jmedchem.2c00046
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Contributors: Nora Khiar-Fernández; Debora Zian; Henar Vázquez-Villa; R. Fernando Martínez; Andrea Escobar-Peña; Román Foronda-Sainz; Manisha Ray; Maria Puigdomenech-Poch; Giovanni Cincilla; Melchor Sanchez-Martinez et al.
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson-Gilford Progeria Syndrome.

ACS central science
2021-06-27 | Journal article
DOI: 10.1021/acscentsci.0c01698
PMID: 34471675
PMC: PMC8393201
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

Chemistry for the Identification of Therapeutic Targets: Recent Advances and Future Directions

European Journal of Organic Chemistry
2021-03-05 | Journal article
DOI: 10.1002/ejoc.202001507
Part of ISSN: 1434-193X
Part of ISSN: 1099-0690
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ

A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration

Journal of Medicinal Chemistry
2020-03-12 | Journal article
DOI: 10.1021/acs.jmedchem.9b01287
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Source: Self-asserted source
NORA KHIAR FERNÁNDEZ
How many people are using ORCID?